Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.BO·BSE·Healthcare
220.80−1.00 (−0.45%)today
As of Nov 5, 12:46 PM IST · May be delayed up to 15 min · INR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close221.80
Open224.30
Day range220.65226.20
52-week range154.90264.65
Off day high−2.39%
Off 52-week high−16.57%
Volume1.28K
Avg. volume (3M)13.21K
Market cap14.59B
EPS (TTM)6.52
Forward P/E—
P/E ratio (TTM)33.87
Dividend yield1.13% (2.50)
Beta (5Y)-0.26
Shares outstanding66.06M
Short interest—
Earnings dateAug 5, 2025
Analyst target—
Profit margin14.31%
Against its peers
Compare in full ›| JAGSNPHARM.BO | RDY | 000623.SZ | RPGLIFE.NS | JUBLPHARMA.BO | 1795.TW | |
|---|---|---|---|---|---|---|
| Market cap | 14.59B | 12.30B | 20.71B | 42.93B | 150.00B | 44.76B |
| P/E (TTM) | 33.9 | 41.0 | 6.8 | 38.7 | 42.7 | 11.8 |
| Forward P/E | — | 22.3 | 7.9 | 27.6 | 18.7 | 7.1 |
| Price/book | 6.1 | 18.0 | 0.6 | 7.1 | 2.1 | 1.9 |
| Dividend yield | 1.13% | 0.56% | 2.88% | 0.92% | 0.53% | 1.61% |
| 1-year change | −0.05% | +6.72% | −16.84% | +6.05% | −19.19% | −42.88% |
| Today | −0.45% | +3.29% | −0.35% | −0.11% | +0.79% | +5.66% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All JAGSNPHARM.BO news ›Jagsonpal Pharmaceuticals’ Q2 FY27 Consolidated Revenue Rises 29% To ₹964 Crore
Mumbai: Jagsonpal Pharmaceuticals Limited on Tuesday announced its unaudited financial results for the quarter and half year ended 30 September 2026, reporting a consolidated revenue increase of 29% to ₹964 crore for Q2 FY27. For the…
From the 4Search news index, newest first.
In the news
2mentions in 30 days
2with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
- freepressjournal.in2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.